https://www.selleckchem.com/pr....oducts/oxiglutatione
EPD used one or more times = 240 vs. 345, p .001). The EPDs used in the SVG-PCI group had a significantly lower prevalence of the slow-flow phenomenon after adjusting for covariates (OR 0.45, 95% CI 0.21-0.91, p = .04). GV-PCI is associated with an increased risk of in-hospital mortality. EDP use in SVG-PCI was associated with a low rate of the slow-flow phenomenon. The usage of EPDs during SVG-PCI is low, with a significant variation among institutions. GV-PCI is associated with an increased risk of in-hospital mortality. ED
Like
Comment
Share
